Novel Approach to DPI Carrier Lactose with Mechanofusion Process with Additives and Evaluation by IGC
Новый подход к использованию лактозы в качестве носителя для ингалятора сухого порошка с применением процесса механофузии с добавками и оценкой методом ИГХ
2006-01-01
SCID: 54.1/kjr5ay8d
Discuss with AI
dry powder inhalerfine particle fractioninverse gas chromatographylactose carriermechanofusion
Figures from the paper
Abstract (AI)
The effect of lactose carrier surface property on the inhalation profile of dry powder inhaler (DPI) was evaluated using a micronized drug (Compound A) by inverse gas chromatography (IGC). Mechanofusion with magnesium stearate (Mg-St) or sucrose stearate increased the fine particle fraction (FPF), considered to be due to decrease in the interaction between Compound A and the lactose carrier. The effect of Compound A concentration on FPF was smaller in mechanofusion-processed lactose compared to intact lactose, especially when processed with Mg-St. The relationship between the IGC parameters of the lactose and FPF was also investigated. FPF increased as both the dispersive component of the surface energy and acidity similarity between the lactose carriers and Compound A increased. Although further investigation is necessary, it could be suggested that acidity similarity decreases the interaction between Compound A and lactose, thus contributing to the increase in the FPF. In conclusion, (1) mechanofusion with Mg-St or sucrose stearate could be an effective method to improve FPF of a DPI drug formulation; (2) IGC would be a valuable method to investigate the interaction between a drug and the DPI carrier; and (3) a relationship between surface acidity and inhalation profile was suggested.
Key Findings
1
Compound A concentration had a smaller effect on fine particle fraction after mechanofusion than with intact lactose, particularly for magnesium stearate-treated lactose.
2
Fine particle fraction increased with both the lactose carrier’s dispersive surface-energy component and acidity similarity to Compound A.
3
Inverse gas chromatography was useful for investigating drug–carrier interactions and suggested that surface acidity influences the inhalation profile.
4
Mechanofusion of lactose with magnesium stearate or sucrose stearate increased the dry powder inhaler fine particle fraction by reducing drug–carrier interactions.
5
Mechanofusion with magnesium stearate or sucrose stearate may effectively improve dry powder inhaler performance.
Research Object
DPI lactose carrier formulations containing micronized Compound A processed by mechanofusion with magnesium stearate or sucrose stearate
Research Subject
Effects of carrier surface properties and mechanofusion additives on drug–lactose interaction and inhalation performance, particularly fine particle fraction (FPF)
Publication Details
Publication Date
2006-01-01
Journal
Publisher
ISSN
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest